Asthma News and Research

RSS
Boehringer Ingelheim's tiotropium shows promising results in patients with severe persistent asthma

Boehringer Ingelheim's tiotropium shows promising results in patients with severe persistent asthma

AIR2 trial: Alair BT System shows therapy benefits in adults with severe uncontrolled asthma

AIR2 trial: Alair BT System shows therapy benefits in adults with severe uncontrolled asthma

Study explores links between asthma, sleep quality and academic performance in urban schoolchildren

Study explores links between asthma, sleep quality and academic performance in urban schoolchildren

Study: Extended azithromycin therapy may offer significant benefits to COPD patients

Study: Extended azithromycin therapy may offer significant benefits to COPD patients

Traffic-related pollutants exacerbate asthma in pregnant women

Traffic-related pollutants exacerbate asthma in pregnant women

Asthma is a potential risk factor for obstructive sleep apnea

Asthma is a potential risk factor for obstructive sleep apnea

Exercise-induced bronchoconstriction (EIB) guidelines: an interview with Dr Jonathan Parsons, The Ohio State University Asthma Center

Exercise-induced bronchoconstriction (EIB) guidelines: an interview with Dr Jonathan Parsons, The Ohio State University Asthma Center

Childhood respiratory infections rather than analgesics usage linked to risk for asthma

Childhood respiratory infections rather than analgesics usage linked to risk for asthma

Hospital emergency departments play growing role in US health care system

Hospital emergency departments play growing role in US health care system

Purified components of ginger help asthma patients breathe more easily

Purified components of ginger help asthma patients breathe more easily

Boehringer Ingelheim to highlight respiratory research work at ATS 2013

Boehringer Ingelheim to highlight respiratory research work at ATS 2013

Neupro reduces PLMS and total NSBP elevations in patients with RLS, study finds

Neupro reduces PLMS and total NSBP elevations in patients with RLS, study finds

Boehringer Ingelheim updates HCPs, patients on COMBIVENT RESPIMAT Inhalation Spray

Boehringer Ingelheim updates HCPs, patients on COMBIVENT RESPIMAT Inhalation Spray

A*STAR, Cytos Biotechnology provide update on Phase 1 clinical trial of H1N1 influenza vaccine

A*STAR, Cytos Biotechnology provide update on Phase 1 clinical trial of H1N1 influenza vaccine

American Association for Respiratory Care names Jefferson a Quality Respiratory Care Institution

American Association for Respiratory Care names Jefferson a Quality Respiratory Care Institution

Community Catalyst study shows dental therapists expand access to people in remote areas

Community Catalyst study shows dental therapists expand access to people in remote areas

Soligenix starts first clinical study for development of SGX203 for pediatric Crohn's disease

Soligenix starts first clinical study for development of SGX203 for pediatric Crohn's disease

ALK, AAFA partner to create unique online resource for people living with allergies

ALK, AAFA partner to create unique online resource for people living with allergies

Sanofi, Regeneron enroll patients in two sarilumab Phase 3 trials for treatment of RA

Sanofi, Regeneron enroll patients in two sarilumab Phase 3 trials for treatment of RA

University of Utah receives $1.9M research award to study asthma in children

University of Utah receives $1.9M research award to study asthma in children

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.